Evidence map›Paper›PMID 27397939›Full record

ArticleAngewandte Chemie (Weinheim an der Bergstrasse, Germany)2016

Enzymatic Macrocyclization of 1,2,3-Triazole Peptide Mimetics.

Emilia Oueis, Marcel Jaspars, Nicholas J Westwood, James H Naismith

Abstract read
In one paragraph

Article in Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. 1,2,3-Triazoles as Biomimetics in Peptide Science.Molecules (Basel, Switzerland) · 2021
    Review
  2. Review
  3. Article
  4. Article
  5. Rapid protein immobilization for thin film continuous flow biocatalysis.Chemical communications (Cambridge, England) · 2016
    Article
  6. Enzymatic Macrocyclization of 1,2,3-Triazole Peptide Mimetics.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emilia OueisBiomedical Science Research Complex University of St Andrews, BSRC North Haugh St Andrews KY16 9ST UK.
Marcel JasparsMarine Biodiscovery Centre, Department of Chemistry University of Aberdeen Old Aberdeen AB24 3UE UK.
Nicholas J WestwoodBiomedical Science Research Complex University of St Andrews, BSRC North Haugh St Andrews KY16 9ST UK.
James H NaismithBiomedical Science Research Complex University of St Andrews, BSRC North Haugh St Andrews KY 16 9 ST UK; State Key Laboratory of Biotherapy Sichuan University China.ORCID 0000-0001-6744-5061

Funding

European Research Council 339367Wellcome Trust
6 · The paper itself

Abstract

The macrocyclization of linear peptides is very often accompanied by significant improvements in their stability and biological activity. Many strategies are available for their chemical macrocyclization, however, enzyme-mediated methods remain of great interest in terms of synthetic utility. To date, known macrocyclization enzymes have been shown to be active on both peptide and protein substrates. Here we show that the macrocyclization enzyme of the cyanobactin family, PatGmac, is capable of macrocyclizing substrates with one, two, or three 1,4-substituted 1,2,3-triazole moieties. The introduction of non-peptidic scaffolds into macrocycles is highly desirable in tuning the activity and physical properties of peptidic macrocycles. We have isolated and fully characterized nine non-natural triazole-containing cyclic peptides, a further ten molecules are also synthesized. PatGmac has now been shown to be an effective and versatile tool for the ring closure by peptide bond formation.

Indexed as

BiotransformationCyanobactinCyclische PeptidePeptidmimetikaTriazol

Identifiers

PMID27397939
PMCPMC4924595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.